Maraviroc
NDC 73141-025, Maraviroc, tablet, film coated, from A2A Integrated Pharmaceuticals.
- Product NDC
- 73141-025
- Status
- Listed
- Labeler
- A2A Integrated Pharmaceuticals
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA217114
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/73141-025 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- MARAVIROC300 mg/1
Pharmacologic classes
CCR5 Co-receptor Antagonist [EPC]; Chemokine Co-receptor 5 Antagonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 73141-025-02 | 73141002502 | 60 TABLET, FILM COATED in 1 BOTTLE (73141-025-02) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/2a16417d-a3b8-483b-9dfe-d5263cc16538
Use it
Look up 73141-025 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/73141-025 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 73141-025. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.